L'OREAL PRIORITISES UV PROTECTION
With UVMune 400, a new generation of filter powered by Mexoryl 400, with maximized performance and quality,
Previous generation sun filters have insufficiently protected skin against ultra-long UVA rays. These long UVA rays penetrate the epidermis the most and are among the main causes of skin aging. They also contribute to the development of skin cancer, along with other UVA and UVB rays. No sun filter was able to block efficiently ultra-long UVA rays from 380 nm which alone accounts for 30% of UV.
UV rays affect our skin to a greater or lesser extent depending on the time of day, the season, the altitude and the weather. According to their wavelengths, we distinguish between UVB (rays between 280 and 320 nm*), short UVA (between 320 and 340 nm), long UVA (from 340-400 nm) and in this range the ultra-long UVA (between 380 and 400 nm).
UVMUNE 400 POWERED BY MEXORYL 400: A BREAKTHROUGH INNOVATION IN SUN PROTECTION
UVMune 400 is the first
'Our L'Oreal R&I teams have successfully risen to the real scientific challenge of inventing a sun filtering technology to cover the UVA zone that was so far less covered. This allows us to provide our broadest filtration and protect the skin from the damaging effects of the sun, even the most insidious. This discovery is fully in line with the Group's approach of providing answers to public health issues, such as the risks linked to skin exposure to UV radiation,' explains Barbara Lavernos, Deputy CEO in charge of Research, Innovation and Technology at
LA ROCHE-POSAY: THE FIRST GROUP BRAND TO BENEFIT FROM UVMUNE 400 TECHNOLOGY
UVMune 400 is a technology that provides broad spectrum photoprotection. La Roche-Posay is the number one dermatologist-recommended skincare brand worldwide and is the first L'Oreal brand to launch UVMune 400 technology, through its Anthelios franchise. A pioneer in sun protection for 30 years, La Roche-Posay has always led the field with products co-developed alongside renowned dermatologists to provide broad protection, and in one of the most complete suncare franchise.
Anthelios UVMune 400 is proven to shield against deep cell damage, which is linked to signs of premature aging, and to prevent DNA lesions, which may lead to skin cancer. Tested on all skin types and phototypes, Anthelios UVMune 400 was launched in pharmacies in
'Sun protection is a key public health issue,' says Laetitia Toupet, La Roche-Posay Global Brand President. 'As a leading brand in suncare, we do our utmost to share derm knowledge and provide best-in-class protection in partnership with dermatologists. We are proud to raise the bar with Anthelios UVMune 400 to protect all types of skin against even the most insidious UV rays.'
About
For over 110 years,
With 85,400 committed employees, a balanced geographical footprint and sales across all distribution networks (e-commerce, mass market, department stores, pharmacies, hair salons, branded and travel retail), in 2021 the Group generated sales amounting to
More information on https://www.loreal.com/en/mediaroom
'This press release does not constitute an offer of sale or solicitation of an offer to purchase
This press release may contain forecast information. While the Company believes that these statements are based on reasonable assumptions as of the date of publication of this press release, they are by nature subject to risks and uncertainties which may lead to a discrepancy between the actual figures and those indicated or suggested in these statements.'
Contact:
Switchboard
T: +33 (0)1 47 56 70 00
Individual shareholders and market regulators
Christian
T: +33 (0)1 47 56 72 06
E: Christian.munich2@loreal.com
(C) 2022 Electronic News Publishing, source